NCT05910827 A Phase Ib/II Study of an Anti-HER3 Antibody, HMBD-001, With Cetuximab +/- Docetaxel in Advanced Squamous Cell Cancers Status RECRUITING Phase PHASE1/PHASE2
NCT05863052 Analyzing Clinical Outcomes and Genomic Data of American Indian Patient Population Status ACTIVE_NOT_RECRUITING Phase N/A
NCT05858229 Neo-adjuvant Treatment for Squamous Cell Carcinoma Using Direct Tumor Injection With RP1. Status ACTIVE_NOT_RECRUITING Phase PHASE1/PHASE2
NCT05854030 Serum Exosomal miRNA Predicting the Therapeutic Efficiency in Lung Squamous Carcinoma Status UNKNOWN Phase N/A
NCT05843032 3D Ultrasound, Specimen Examination by Surgeon, and MRI in Surgical Margin Assessment Status UNKNOWN Phase NA
NCT05693116 Survival and Prognostic Factors of Squamous Cell Carcinoma of the Nasal Vestibule Status RECRUITING Phase N/A
NCT05681039 Phase 2 Trial of Neoadjuvant and Adjuvant Tiragolumab Plus Atezolizumab in Patients With Newly Diagnosed PD-L1 CPS Positive Resectable Stage 3-4 Oral Cavity Squamous Cell Carcinoma (OCSCC). Status RECRUITING Phase PHASE2
NCT05574101 A Study of Radiation Therapy and Cemiplimab for People With Skin Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT05535023 Phase 2 Study of Neoadjuvant SAR444245 Plus Cemiplimab in HPV Related Oropharynx Squamous Cell Carcinoma Status WITHDRAWN Phase PHASE2
NCT05402046 Clinical vAlidation of a MobilE appLication ("ProRodinki") in the Assessment of the maLignant skIn neoplAsms Status UNKNOWN Phase NA
NCT05340543 Ex-vivo Examination of Excisions of Skin Tumors by Confocal Optical Coherence Tomography (LC-OCT) With Integrated Dermoscopy and Comparison With Histology (DERMOCTAV) Status UNKNOWN Phase N/A
NCT05337163 A Multicenter Clinical Trial of Sputum DNA Testing for Lung Cancer in China Status COMPLETED Phase N/A
NCT05202860 Impact of Human Papillomavirus (HPV) Vaccination on Burden of Disease in Patients with Actinic Keratosis Status ACTIVE_NOT_RECRUITING Phase PHASE2